Congratulations on the PhD, Dr. Tori Duback!
Tori’s terrific T cells targeted tumors so effectively that today she has earned herself a PhD and the title of “Doctor”.
Tori joined ABNEL back in the fall of 2022 as a Chemical Engineering Industry PhD student with Sana Biotechnology. While only at Northeastern for 2.5 years, Tori has made the most of her time. In addition to continuing her day job at Sana Biotechnology, Tori also managed to find time for her thesis work, getting engaged, and buying a house. Truly one of the most proliferative students to have graced our lab.
Finally finishing her work on targeted T cell therapeutics, Tori plans to continue her work on targeted T cell therapeutics…but only at Sana Biotechnology and with (hopefully) a bit more free time.
Congrats again on the PhD, Tori, and we hope to see you around!
Best of luck,
ABNEL
AIP publishes SciLight commentary on recent ABNEL collaboration review
AIP published a commentary on a recent review paper led by Max A. Winkelman and Prof. Guohao Dai in collaboration with ABNEL and LNNR. More information can be found in the link below: https://aip.scitation.org/doi/10.1063/10.0003794 Original Publication:...
Abby publishes commentary calling to address racial disparities in research funding
Abby was a signatory on a recent commentary published in Cell calling for increased action to address present racial disparities in scientific funding. More details can be found in a news release and the commentary itself. #fundblackscientists